Literature DB >> 29475795

Race and stroke in an atrial fibrillation inception cohort: Findings from the Penn Atrial Fibrillation Free study.

Parin J Patel1, Ronit Katz2, Yuliya Borovskiy3, Anthony Killian3, Joshua M Levine4, Nelson W McNaughton3, David Callans3, Gregory Supple3, Sanjay Dixit3, Andrew E Epstein3, Francis E Marchlinski3, Rajat Deo5.   

Abstract

BACKGROUND: Stroke may be the initial manifestation of atrial fibrillation (AF). Limited studies, however, have evaluated racial differences in stroke before the diagnosis of AF.
OBJECTIVE: We assessed racial differences in strokes that occurred before and after AF diagnosis in the Penn Atrial Fibrillation Free study.
METHODS: The Penn Atrial Fibrillation Free study consists of 56,835 patients from the University of Pennsylvania Health System who were free of AF at the index visit. We developed an inception cohort of 3507 patients with incident AF and without any remote history of stroke.
RESULTS: Among the AF inception cohort, there were 538 patients with ischemic strokes and 54 with hemorrhagic strokes. Nearly half (n = 254; 47%) of the ischemic strokes occurred within a 6-month period before the diagnosis of AF. Of these, the majority of strokes occurred either on the day of (n = 158) or within a 7-day period before (n = 30) the diagnosis of incident AF. The remaining 284 (53%) ischemic strokes occurred a median of 3.6 years (interquartile range 1.9-5.4 years) after AF diagnosis. Compared with whites, blacks had an independently higher risk of having an ischemic stroke either before (adjusted odds ratio 1.37; 95% confidence interval 1.03-1.81) or after (adjusted hazard ratio 1.67; 95% confidence interval 1.30-2.14) AF diagnosis.
CONCLUSION: In the population with incident AF, nearly half of the ischemic strokes occurred before the diagnosis of AF. Compared with whites, blacks had a higher risk of developing an ischemic stroke that persisted whether the stroke occurred in the period either before or after AF diagnosis.
Copyright © 2017 Heart Rhythm Society. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Atrial fibrillation; Ethnicity; Population; Race; Risk factor; Stroke

Mesh:

Year:  2018        PMID: 29475795      PMCID: PMC5879006          DOI: 10.1016/j.hrthm.2017.11.025

Source DB:  PubMed          Journal:  Heart Rhythm        ISSN: 1547-5271            Impact factor:   6.343


  28 in total

1.  The incidence of deep and lobar intracerebral hemorrhage in whites, blacks, and Hispanics.

Authors:  D L Labovitz; A Halim; B Boden-Albala; W A Hauser; R L Sacco
Journal:  Neurology       Date:  2005-08-23       Impact factor: 9.910

2.  Racial variation in initial stroke severity.

Authors:  M R Jones; R D Horner; L J Edwards; J Hoff; S B Armstrong; C A Smith-Hammond; D B Matchar; E Z Oddone
Journal:  Stroke       Date:  2000-03       Impact factor: 7.914

Review 3.  Racial and ethnic differences in cardiovascular disease risk factors: a systematic review.

Authors:  Anita K Kurian; Kathryn M Cardarelli
Journal:  Ethn Dis       Date:  2007       Impact factor: 1.847

4.  2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society.

Authors:  Craig T January; L Samuel Wann; Joseph S Alpert; Hugh Calkins; Joaquin E Cigarroa; Joseph C Cleveland; Jamie B Conti; Patrick T Ellinor; Michael D Ezekowitz; Michael E Field; Katherine T Murray; Ralph L Sacco; William G Stevenson; Patrick J Tchou; Cynthia M Tracy; Clyde W Yancy
Journal:  Circulation       Date:  2014-03-28       Impact factor: 29.690

Review 5.  Screening for Atrial Fibrillation: A Report of the AF-SCREEN International Collaboration.

Authors:  Ben Freedman; John Camm; Hugh Calkins; Jeffrey S Healey; Mårten Rosenqvist; Jiguang Wang; Christine M Albert; Craig S Anderson; Sotiris Antoniou; Emelia J Benjamin; Giuseppe Boriani; Johannes Brachmann; Axel Brandes; Tze-Fan Chao; David Conen; Johan Engdahl; Laurent Fauchier; David A Fitzmaurice; Leif Friberg; Bernard J Gersh; David J Gladstone; Taya V Glotzer; Kylie Gwynne; Graeme J Hankey; Joseph Harbison; Graham S Hillis; Mellanie T Hills; Hooman Kamel; Paulus Kirchhof; Peter R Kowey; Derk Krieger; Vivian W Y Lee; Lars-Åke Levin; Gregory Y H Lip; Trudie Lobban; Nicole Lowres; Georges H Mairesse; Carlos Martinez; Lis Neubeck; Jessica Orchard; Jonathan P Piccini; Katrina Poppe; Tatjana S Potpara; Helmut Puererfellner; Michiel Rienstra; Roopinder K Sandhu; Renate B Schnabel; Chung-Wah Siu; Steven Steinhubl; Jesper H Svendsen; Emma Svennberg; Sakis Themistoclakis; Robert G Tieleman; Mintu P Turakhia; Arnljot Tveit; Steven B Uittenbogaart; Isabelle C Van Gelder; Atul Verma; Rolf Wachter; Bryan P Yan
Journal:  Circulation       Date:  2017-05-09       Impact factor: 29.690

6.  Atrial fibrillation in patients with cryptogenic stroke.

Authors:  David J Gladstone; Melanie Spring; Paul Dorian; Val Panzov; Kevin E Thorpe; Judith Hall; Haris Vaid; Martin O'Donnell; Andreas Laupacis; Robert Côté; Mukul Sharma; John A Blakely; Ashfaq Shuaib; Vladimir Hachinski; Shelagh B Coutts; Demetrios J Sahlas; Phil Teal; Samuel Yip; J David Spence; Brian Buck; Steve Verreault; Leanne K Casaubon; Andrew Penn; Daniel Selchen; Albert Jin; David Howse; Manu Mehdiratta; Karl Boyle; Richard Aviv; Moira K Kapral; Muhammad Mamdani
Journal:  N Engl J Med       Date:  2014-06-26       Impact factor: 91.245

7.  Racial/Ethnic differences in ischemic stroke rates and the efficacy of warfarin among patients with atrial fibrillation.

Authors:  Albert Yuh-Jer Shen; Janis F Yao; Somjot S Brar; Michael B Jorgensen; Xunzhang Wang; Wansu Chen
Journal:  Stroke       Date:  2008-07-17       Impact factor: 7.914

8.  Optimal QT interval correction formula in sinus tachycardia for identifying cardiovascular and mortality risk: Findings from the Penn Atrial Fibrillation Free study.

Authors:  Parin J Patel; Yuliya Borovskiy; Anthony Killian; Ralph J Verdino; Andrew E Epstein; David J Callans; Francis E Marchlinski; Rajat Deo
Journal:  Heart Rhythm       Date:  2015-11-10       Impact factor: 6.343

9.  Edoxaban versus warfarin in patients with atrial fibrillation.

Authors:  Robert P Giugliano; Christian T Ruff; Eugene Braunwald; Sabina A Murphy; Stephen D Wiviott; Jonathan L Halperin; Albert L Waldo; Michael D Ezekowitz; Jeffrey I Weitz; Jindřich Špinar; Witold Ruzyllo; Mikhail Ruda; Yukihiro Koretsune; Joshua Betcher; Minggao Shi; Laura T Grip; Shirali P Patel; Indravadan Patel; James J Hanyok; Michele Mercuri; Elliott M Antman
Journal:  N Engl J Med       Date:  2013-11-19       Impact factor: 91.245

10.  Atrial fibrillation, stroke, and anticoagulation in Medicare beneficiaries: trends by age, sex, and race, 1992-2010.

Authors:  Gautam R Shroff; Craig A Solid; Charles A Herzog
Journal:  J Am Heart Assoc       Date:  2014-06-03       Impact factor: 5.501

View more
  2 in total

1.  Racial and Urban-Rural Difference in the Frequency of Ischemic Stroke as Initial Manifestation of Atrial Fibrillation.

Authors:  Jingchuan Guo; Nico Gabriel; Jared W Magnani; Utibe R Essien; Walid F Gellad; Maria M Brooks; Ludovic Trinquart; Emelia J Benjamin; Inmaculada Hernandez
Journal:  Front Public Health       Date:  2021-11-05

2.  A cross-sectional analysis of racial differences in accelerated aging and cognitive function among patients with atrial fibrillation: The SAGE-AF study: Forrester, Accelerated aging and cognitive function.

Authors:  Sarah N Forrester; David D McManus; Jane S Saczynski; Isabelle C Pierre-Louis; Benita A Bamgbade; Catarina I Kiefe
Journal:  EClinicalMedicine       Date:  2021-07-31
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.